Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

Moderna announced today (January 25) plans for testing two different booster vaccines aimed at the SARS-CoV-2 variant B.1.351, also known as 501Y.V2, that emerged in South Africa and has now spread to ...

Both Moderna and Pfizer have updated the formulations ... Is there any reason to wait to get the new booster shots when they become available? Last year, some experts recommended waiting until ...

With Omicron still the prevailing strain of COVID-19 around the world, the new shot is now Moderna's "lead candidate for a fall 2022 booster," he added. Some expert groups, including the Joint ...

The new shots from Pfizer and Moderna are designed to target the KP ... rather than later since she has not been infected or had a booster in some time. Sax recommends that his patients wait ...

Under President Trump, the Food and Drug Administration may no longer approve seasonal COVID-19 vaccines updated for the ...

As reported by The New York Times ... to the Ómicron variant compared to those who received a booster dose of the existing Moderna vaccine. T he improvement was also manifested in the duration ...

A 50-microgram dose of the new vaccine doubles the neutralizing antibody responses against Omicron compared with the original booster at the same dosage, Moderna said. Spikevax meets the FDA's ...

Moderna's new jab is an updated version of its Spikevax vaccine, and includes sequences from the original Wuhan strain of SARS-CoV-2, as well as from the Omicron BA.1 subvariant ...

It looked at differences between patients given a Moderna booster after having had two jabs of the Pfizer vaccine and those who received the Pfizer vaccine three times. While about 70 percent of ...